Pure Global

25-Hydroxy Vitamin D Assay Kit (Latex Immunoturbidimetric Method) - NMPA Registration 京械注准20232400581

Access comprehensive regulatory information for 25-Hydroxy Vitamin D Assay Kit (Latex Immunoturbidimetric Method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 京械注准20232400581 and owned by Beijing Homa Biological Engineering Co., Ltd.. The device was approved on September 19, 2023.

This page provides complete registration details including registrant information, province location (Beijing), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.

Free Database
Powered by Pure Global AI
NMPA Official Data
Class II
京械注准20232400581
25-Hydroxy Vitamin D Assay Kit (Latex Immunoturbidimetric Method)
25-羟基维生素D测定试剂盒(胶乳免疫比浊法)
NMPA Registration Number: 京械注准20232400581
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Use
English

This reagent is used for the quantitative determination of the concentration of 25-hydroxyvitamin D [25-OH VD] in human serum in vitro.

中文

本试剂用于体外定量测定人血清中25-羟基维生素D[25-OH VD]的浓度。

Device Classification
Device Class
Class II
Model Specifications
Reagent 1:1; 60mL, reagent 2:1; 15mL; Reagent 1: 2; 60mL, reagent 2:2; 15mL; Reagent 1:1; 40mL, reagent 2:1; 10mL; Reagent 1:1; 20mL, reagent 2:1; 5mL; Reagent 1: 24; 3.8mL, reagent 2:6; 3.8mL; Reagent 1: 16; 3.8mL, reagent 2:4; 3.8mL; Reagent 1:1; 70mL, reagent 2:1; 21mL; Reagent 1:1; 64mL, reagent 2:1; 16mL; Reagent 1:1; 84mL, reagent 2:1; 26mL; Reagent 1:1; 42mL, reagent 2:1; 12mL; Reagent 1:1; 56mL, reagent 2:1; 14mL; Reagent 1:1; 60mL, reagent 2:1; 20mL; Reagent 1: 2; 60mL, reagent 2:2; 20mL; Reagent 1:1; 45mL, reagent 2:1; 15mL; Reagent 1:1; 18mL, reagent 2:1; 6mL; Reagent 1: 24; 3.8mL, reagent 2:12; 2.6mL; Reagent 1: 12; 3.8mL, reagent 2:6; 2.6mL; Reagent 1:1; 70mL, reagent 2:1; 26mL; Reagent 1:1; 63mL, reagent 2:1; 21mL; Reagent 1:1; 84mL, reagent 2:1; 28mL; Reagent 1:1; 42mL, reagent 2:1; 14mL; Reagent 1:1; 57mL, reagent 2:1; 19mL; Calibrator (optional): 5; 0.5mL;5; 1mL;5; 2mL;5; 3mL; Quality control products (optional): 2; 0.5mL;2; 1mL;2; 2mL;2; 3mL;2; 5mL. Note: Calibrators and quality controls are batch specific, and the specific concentrations are shown on the label.
试剂1:1;60mL、试剂2:1;15mL; 试剂1:2;60mL、试剂2:2;15mL; 试剂1:1;40mL、试剂2:1;10mL; 试剂1:1;20mL、试剂2:1;5mL; 试剂1:24;3.8mL、试剂2:6;3.8mL; 试剂1:16;3.8mL、试剂2:4;3.8mL; 试剂1:1;70mL、试剂2:1;21mL; 试剂1:1;64mL、试剂2:1;16mL; 试剂1:1;84mL、试剂2:1;26mL; 试剂1:1;42mL、试剂2:1;12mL; 试剂1:1;56mL、试剂2:1;14mL; 试剂1:1;60mL、试剂2:1;20mL; 试剂1:2;60mL、试剂2:2;20mL; 试剂1:1;45mL、试剂2:1;15mL; 试剂1:1;18mL、试剂2:1;6mL; 试剂1:24;3.8mL、试剂2:12;2.6mL; 试剂1:12;3.8mL、试剂2:6;2.6mL; 试剂1:1;70mL、试剂2:1;26mL; 试剂1:1;63mL、试剂2:1;21mL; 试剂1:1;84mL、试剂2:1;28mL; 试剂1:1;42mL、试剂2:1;14mL; 试剂1:1;57mL、试剂2:1;19mL; 校准品(选配):5;0.5mL;5;1mL;5;2mL;5;3mL; 质控品(选配):2;0.5mL;2;1mL;2;2mL;2;3mL;2;5mL。 注:校准品、质控品具有批特异性,具体浓度见标签。
Approval Department
Beijing Municipal Drug Administration
北京市药品监督管理局
Registration Information
Registration Number
京械注准20232400581
Approval Date
September 19, 2023
Expiry Date
September 18, 2028
Registrant
Name
Beijing Homa Biological Engineering Co., Ltd.
北京豪迈生物工程股份有限公司
Province/Region
Beijing
北京
Address
East of the first and third floors of Building 7, No. 28 Yuhua Road, Linkong Economic Core Zone, Shunyi District, Beijing
北京市顺义区临空经济核心区裕华路28号7号楼一层、三层东侧
Production Facility
Production Address
北京市顺义区临空经济核心区裕华路28号7号楼一层、三层东侧
Structure and Composition
English

This reagent consists of Reagent 1 (R1), Reagent 2 (R2), Calibrator and Quality Control Reagent 1 (R1): TRIS buffer 50 mmol/L MgCL2 100mmol/L Glucose hexaphosphate 0.15mmol/L BSA 5g/L Sodium azide 1g/L Reagent 2 (R2): TRIS buffer 50 mmol/L Latex granule suspension coated with anti-25-hydroxyvitamin D antibody 0.15% BSA 5g/L Sodium azide 1g/L Calibrators (5 levels of liquid, phosphate buffer matrix) with target concentration ranges (level 1:0 ng/mL, level 2:15.0~35.0 ng/mL, level 3:45.0~70.0 ng/mL, level 4: 85.0~115.0 ng/mL, level 5:116.0~155.0 ng/mL). The control (2 levels of liquid, phosphate buffer matrix), the target concentration range was (level 1:10.0~40.0ng/mL, level 2:42.0~110.0ng/mL). Note: 1) Calibrators and quality control products have batch specificity, and the specific concentration is shown on the label. 2) Calibrator traceability: According to the requirements of GB/T 21415-2008 "Metrology traceability of measurement of calibrators and value assignment of control substances in biological samples of in vitro diagnostic medical devices", the source, assignment and measurement uncertainty of the calibrator can be traced to the standard substance (number: NIST SRM972).

中文

本试剂由试剂1(R1)、试剂2(R2)、校准品和质控品组成 试剂1(R1): TRIS缓冲液 50mmol/L MgCL2 100mmol/L 葡萄糖六磷酸 0.15mmol/L BSA 5g/L 叠氮钠 1g/L 试剂2(R2): TRIS缓冲液 50mmol/L 包被抗25-羟基维生素D抗体的胶乳颗粒悬浊液 0.15% BSA 5g/L 叠氮钠 1g/L 校准品(5水平液体,磷酸盐缓冲液基质),目标浓度范围分别为(水平1:0 ng/mL、水平2:15.0~35.0 ng/mL、水平3:45.0~70.0 ng/mL、水平4:85.0~115.0 ng/mL、水平5:116.0~155.0 ng/mL)。 质控品(2水平液体,磷酸盐缓冲液基质),目标浓度范围分别为(水平1:10.0~40.0ng/mL、水平2:42.0~110.0ng/mL)。 注:1)校准品、质控品具有批特异性,具体浓度见标签。2)校准品溯源性:按照GB/T 21415-2008《体外诊断医疗器械生物样品中量的测量校准品和控制物质赋值的计量学溯源性》的要求提供校准品的来源、赋值以及测量不确定度等内容,溯源至国际标准物质(编号:NIST SRM972)。

Storage Conditions and Expiration
English

<span style="f

Additional Information
Appendix
产品技术要求、说明书